Efficacy of ALK5 inhibition in myelofibrosis-Reference-Cited by-同舟云学术

Efficacy of ALK5 inhibition in myelofibrosis

Published:2017-04-06 Issue:7 Volume:2 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Yue Lanzhu^ORCID,Bartenstein Matthias^ORCID,Zhao Wanke,Ho Wanting Tina,Han Ying,Murdun Cem,Mailloux Adam W.,Zhang Ling,Wang Xuefeng,Budhathoki Anjali,Pradhan Kith,Rapaport Franck,Wang Huaquan,Shao Zonghong,Ren Xiubao,Steidl Ulrich,Levine Ross L.,Zhao Zhizhuang Joe,Verma Amit,Epling-Burnette Pearlie K.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/90932/files/pdf

Reference70 articles.

1. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms;Tefferi;Leukemia,2008

2. A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders

3. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1;Tefferi;Leukemia,2010

4. Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

5. Pathogenesis of Myelofibrosis With Myeloid Metaplasia

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thioamides in medicinal chemistry and as small molecule therapeutic agents;European Journal of Medicinal Chemistry;2024-11

2. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta;Biomedicine & Pharmacotherapy;2024-06

3. Design, synthesis and evaluation of a pyrazolo[3,4-d]pyrimidine derivative as a novel and potent TGFβ1R1 inhibitor;European Journal of Medicinal Chemistry;2024-05

4. SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms;American Journal of Hematology;2024-03-05

5. SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm;Blood Cancer Journal;2023-11-27